Presentation is loading. Please wait.

Presentation is loading. Please wait.

The Fenway Institute, Fenway Health, Boston, MA

Published byJade Conley Modified over 6 years ago

Similar presentations

Presentation on theme: "The Fenway Institute, Fenway Health, Boston, MA"— Presentation transcript:

1 The Fenway Institute, Fenway Health, Boston, MA
Welcome to STI 2018 Kenneth H. Mayer, M.D. The Fenway Institute, Fenway Health, Boston, MA Department of Medicine, Beth Israel Deaconess Medical Center/Harvard Medical School

2 Disclosures Unrestricted research grants Gilead ViiV
Relations that could be relevant for the meeting Company names Unrestricted research grants Gilead ViiV NIH (NIAID, NIMH, NICHD) Scientific Advisory boards Merck

3 HIV and STI Synergy Inflammation and/or ulceration BIOLOGY
PrEP and TasP ↑HIV transmission and/or acquisition BEHAVIOR STI Condomless sex Multiple partners EPIDEMIOLOGY Higher risk partners, ↑ risk of HIV-infected partner

4 HIV and STI Synergy Inflammation and/or ulceration BIOLOGY
PrEP and TasP ↑HIV transmission and/or acquisition BEHAVIOR STI Condomless sex Multiple partners EPIDEMIOLOGY Higher risk partners, ↑ risk of HIV-infected partner

5 Major Sessions Setting the stage: epidemiology
Key and marginalized populations: factors driving STI epidemics Transmission dynamics Clinical approaches to STI management Emerging STI Diagnostics Best practices and the future of sexual health Emerging issues regarding the global HIV and STI response

6 Ground Rules Full schedule, need to stay on time
Many stakeholders, important to listen to all voices Ample time for informal conversation, during coffee breaks, lunch, poster sessions, reception We hope to publish a scholarly special issue highlighting key data from the meeting

7 STI2018 Organizing Committee
Birgit van Benthem, National Institute for Public Health and the Environment (RIVM), The Netherlands Jan van Bergen, Soa Aids Nederland, Amsterdam | Academic Medical Center, University of Amsterdam |  National Institute for Public Health and the Environment (RIVM), The Netherlands Silke David, National Institute for Public Health and the Environment (RIVM), The Netherlands Udi Davidovich, Public Health Service of Amsterdam (GGD), The Netherlands Arjan Hogewoning, Public Health Service of Amsterdam (GGD), The Netherlands Elske Hoornenborg, Public Health Service of Amsterdam (GGD) The Netherlands Marina Klein, McGill University and CIHR Canadian HIV Trials Network, Canada Kenneth Ngure, Jomo Kenyatta University of Agriculture and Technology, Kenya | Department of Global Health, University of Washington, United States Nneka Nwokolo, Chelsea and Westminster Hospital, United Kingdom Maria Oud, Public Health Service of Amsterdam (GGD), The Netherlands Sébastien Morin, International AIDS Society, Switzerland Maria Prins, Public Health Service of Amsterdam (GGD) | Academic Medical Center, University of Amsterdam, The Netherlands Jürgen Rockstroh, University of Bonn, Germany Mauro Schechter, Universidade Federal do Rio de Janeiro, Brazil Maarten Schim van der Loeff, Public Health Service of Amsterdam (GGD) | Academic Medical Center, University of Amsterdam, The Netherlands Darrell Tan, Li Ka Shing Knowledge Institute, Canada Clarissa Vergunst, Public Health Service of Amsterdam (GGD), The Netherlands

8 Thanks to STI 2018 partners

Download ppt "The Fenway Institute, Fenway Health, Boston, MA"

Similar presentations

Www.ias2013.org Kuala Lumpur, Malaysia, 30 June - 3 July 2013 How to manage virologic non- responders, non-genotype 1, relapsers IAS 2013, Session: HCV.

Kuala Lumpur, Malaysia, 30 June - 3 July 2013 How to manage virologic non- responders, non-genotype 1, relapsers IAS 2013, Session: HCV.
Using longitudinal, population-based HIV surveillance to measure the real-world impacts of ART scale-up in KwaZulu- Natal, South Africa Frank Tanser Presentation.

Using longitudinal, population-based HIV surveillance to measure the real-world impacts of ART scale-up in KwaZulu- Natal, South Africa Frank Tanser Presentation.
Ensuring Community Participation in Developing An HIV Prevention Intervention for Psychiatric Settings: A US-Brazil Collaboration M.L. Wainberg 1, V. Terto.

Ensuring Community Participation in Developing An HIV Prevention Intervention for Psychiatric Settings: A US-Brazil Collaboration M.L. Wainberg 1, V. Terto.
THE NATIONAL CENTER for RESPONSIBLE GAMING 1996 ---

THE NATIONAL CENTER for RESPONSIBLE GAMING
EFFICACY OF A RANDOMIZED INTERVENTION TRIAL PROMOTING FEMALE CONDOM USE AMONG FEMALE SOUTH AFRICAN TERTIARY STUDENTS Jenni Smit, Susie Hoffman, Zonke Mabude,

EFFICACY OF A RANDOMIZED INTERVENTION TRIAL PROMOTING FEMALE CONDOM USE AMONG FEMALE SOUTH AFRICAN TERTIARY STUDENTS Jenni Smit, Susie Hoffman, Zonke Mabude,
Institute for Health and Society Institute for Health and Society Improving Health and Advancing Health Equity Through Community and Academic Partnerships.

Institute for Health and Society Institute for Health and Society Improving Health and Advancing Health Equity Through Community and Academic Partnerships.
1 A frank dialogue on the future of HIV treatment All the way from the factory to the patient Sunday 20 th July 2014, 13:30 – 15:30 Presented at the 20.

1 A frank dialogue on the future of HIV treatment All the way from the factory to the patient Sunday 20 th July 2014, 13:30 – 15:30 Presented at the 20.
The Overlap of HIV, Key Populations and Psycho-Stimulant drugs CRISTINA PIMENTA, PhD Brazilian Ministry of Health National AIDS Programme Consultant.

The Overlap of HIV, Key Populations and Psycho-Stimulant drugs CRISTINA PIMENTA, PhD Brazilian Ministry of Health National AIDS Programme Consultant.
Washington D.C., USA, 22-27 July 2012www.aids2012.org Treatment as Prevention: It is complex: Let us work on it Kenneth H. Mayer Fenway Health Beth Israel.

Washington D.C., USA, July 2012www.aids2012.org Treatment as Prevention: It is complex: Let us work on it Kenneth H. Mayer Fenway Health Beth Israel.
Use and acceptability of biomedical HIV prevention technologies among MSM and MSW in Vietnam Donn Colby, MD, MPH Harvard Medical School AIDS Initiative.

Use and acceptability of biomedical HIV prevention technologies among MSM and MSW in Vietnam Donn Colby, MD, MPH Harvard Medical School AIDS Initiative.
Sustained Treatment as Prevention: Unprotected sex and increases in virological suppression after HAART initiation among participants in HPTN 052 1 K.H.

Sustained Treatment as Prevention: Unprotected sex and increases in virological suppression after HAART initiation among participants in HPTN K.H.
Employee health and wellness metrics, measurements, and evaluation - - the building blocks for ROI David A. Alter, M.D., Ph.D., F.R.C.P.C Senior Scientist,

Employee health and wellness metrics, measurements, and evaluation - - the building blocks for ROI David A. Alter, M.D., Ph.D., F.R.C.P.C Senior Scientist,
Jesse L. Clark 1, Jerome T. Galea 1, Hector J. Salvatierra 2, Kelika A. Konda 1, Alex Carballo-Dieguez 3, Thomas J. Coates 1, Carlos F. Caceres 2 1. Department.

Jesse L. Clark 1, Jerome T. Galea 1, Hector J. Salvatierra 2, Kelika A. Konda 1, Alex Carballo-Dieguez 3, Thomas J. Coates 1, Carlos F. Caceres 2 1. Department.
Fred Gordin Chief, Infectious Diseases Veterans Affairs Medical Center; Washington DC Professor of Medicine; The George Washington University

Fred Gordin Chief, Infectious Diseases Veterans Affairs Medical Center; Washington DC Professor of Medicine; The George Washington University
Welcome to the 10 th Anniversary Meeting of the St. Louis Diabetes Coalition December 4, 2008.

Welcome to the 10 th Anniversary Meeting of the St. Louis Diabetes Coalition December 4, 2008.
Anticipated Risk Compensation with Pre-Exposure Prophylaxis Use among North American Men who have Sex with Men Using an Internet Social Network D Krakower,

Anticipated Risk Compensation with Pre-Exposure Prophylaxis Use among North American Men who have Sex with Men Using an Internet Social Network D Krakower,
Myron S. Cohen, MD Protocol Chair 6 th IAS Conference, Rome, Italy July 18, 2011 HPTN 052: Summary.

Myron S. Cohen, MD Protocol Chair 6 th IAS Conference, Rome, Italy July 18, 2011 HPTN 052: Summary.
Threshold, Amory Faulkner, oil on canvas 1 The prospects of elimination of HIV with test and treat strategy Mirjam Kretzschmar 1,2 Maarten Schim van der.

Threshold, Amory Faulkner, oil on canvas 1 The prospects of elimination of HIV with test and treat strategy Mirjam Kretzschmar 1,2 Maarten Schim van der.
HIV, Race and Risk in Atlanta, GA: Data from Emory University Studies Patrick Sullivan, DVM, PhD Emory University Center for AIDS Research.

HIV, Race and Risk in Atlanta, GA: Data from Emory University Studies Patrick Sullivan, DVM, PhD Emory University Center for AIDS Research.
Www.med.unc.edu/idig ( ↑ check it). Careers in ID Medicine ID Fellowships: 2-3 years, following residencies in Internal Medicine or Pediatrics Primary.

( ↑ check it). Careers in ID Medicine ID Fellowships: 2-3 years, following residencies in Internal Medicine or Pediatrics Primary.

Similar presentations

Ads by Google